Intra-Cellular Therapies, Inc. Quarterly Operating Lease, Liability in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Intra-Cellular Therapies, Inc. quarterly Operating Lease, Liability history and growth rate from Q1 2019 to Q2 2024.
  • Intra-Cellular Therapies, Inc. Operating Lease, Liability for the quarter ending June 30, 2024 was $18.3M, a 1.66% increase year-over-year.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $18.3M +$298K +1.66% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $16.4M -$2.12M -11.4% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $16.9M -$3.1M -15.5% Dec 31, 2023 10-K 2024-02-22
Q3 2023 $17.5M Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $18M Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $18.5M Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $20M -$5.37M -21.1% Dec 31, 2022 10-K 2023-03-01
Q4 2021 $25.4M -$3.69M -12.7% Dec 31, 2021 10-K 2023-03-01
Q3 2021 $26.4M -$2.7M -9.28% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $27.3M +$2.2M +8.77% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $28.2M +$5.3M +23.1% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $29.1M +$5.96M +25.7% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $29.1M +$6.54M +29% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $25.1M +$2.27M +9.94% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $22.9M -$832K -3.51% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $23.1M Dec 31, 2019 10-K 2020-03-02
Q3 2019 $22.6M Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $22.8M Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $23.7M Mar 31, 2019 10-Q 2019-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.